Application 090781

Type
ANDA
Sponsor
GLENMARK GENERICS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001PRAMIPEXOLE DIHYDROCHLORIDEPRAMIPEXOLE DIHYDROCHLORIDETABLET;ORAL0.125MGNoNo
002PRAMIPEXOLE DIHYDROCHLORIDEPRAMIPEXOLE DIHYDROCHLORIDETABLET;ORAL0.25MGNoNo
003PRAMIPEXOLE DIHYDROCHLORIDEPRAMIPEXOLE DIHYDROCHLORIDETABLET;ORAL0.5MGNoNo
004PRAMIPEXOLE DIHYDROCHLORIDEPRAMIPEXOLE DIHYDROCHLORIDETABLET;ORAL1MGNoNo
005PRAMIPEXOLE DIHYDROCHLORIDEPRAMIPEXOLE DIHYDROCHLORIDETABLET;ORAL1.5MGNoNo
006PRAMIPEXOLE DIHYDROCHLORIDEPRAMIPEXOLE DIHYDROCHLORIDETABLET;ORAL0.75MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 6 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A090781-001PRAMIPEXOLE DIHYDROCHLORIDEPRAMIPEXOLE DIHYDROCHLORIDE0.125MGTABLET / ORALAB2010-10-08
A090781-002PRAMIPEXOLE DIHYDROCHLORIDEPRAMIPEXOLE DIHYDROCHLORIDE0.25MGTABLET / ORALABRS2010-10-08
A090781-003PRAMIPEXOLE DIHYDROCHLORIDEPRAMIPEXOLE DIHYDROCHLORIDE0.5MGTABLET / ORALAB2010-10-08
A090781-004PRAMIPEXOLE DIHYDROCHLORIDEPRAMIPEXOLE DIHYDROCHLORIDE1MGTABLET / ORALAB2010-10-08
A090781-005PRAMIPEXOLE DIHYDROCHLORIDEPRAMIPEXOLE DIHYDROCHLORIDE1.5MGTABLET / ORALAB2010-10-08
A090781-006PRAMIPEXOLE DIHYDROCHLORIDEPRAMIPEXOLE DIHYDROCHLORIDE0.75MGTABLET / ORALAB2015-09-11

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 6 matching rows.

Application-product, TE code table
Application-productTE code
A090781-001AB
A090781-002AB
A090781-003AB
A090781-004AB
A090781-005AB
A090781-006AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06A090781-001PRAMIPEXOLE DIHYDROCHLORIDE0.125MGTABLET / ORALAB2010-10-08a50c72e98297…
2026-08-01 22:54:322026-06A090781-002PRAMIPEXOLE DIHYDROCHLORIDE0.25MGTABLET / ORALABRS2010-10-08a50c72e98297…
2026-08-01 22:54:322026-06A090781-003PRAMIPEXOLE DIHYDROCHLORIDE0.5MGTABLET / ORALAB2010-10-08a50c72e98297…
2026-08-01 22:54:322026-06A090781-004PRAMIPEXOLE DIHYDROCHLORIDE1MGTABLET / ORALAB2010-10-08a50c72e98297…
2026-08-01 22:54:322026-06A090781-005PRAMIPEXOLE DIHYDROCHLORIDE1.5MGTABLET / ORALAB2010-10-08a50c72e98297…
2026-08-01 22:54:322026-06A090781-006PRAMIPEXOLE DIHYDROCHLORIDE0.75MGTABLET / ORALAB2015-09-11a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-01 22:54:322026-06A090781-001AB1a50c72e98297…
2026-08-01 22:54:322026-06A090781-002AB1a50c72e98297…
2026-08-01 22:54:322026-06A090781-003AB1a50c72e98297…
2026-08-01 22:54:322026-06A090781-004AB1a50c72e98297…
2026-08-01 22:54:322026-06A090781-005AB1a50c72e98297…
2026-08-01 22:54:322026-06A090781-006AB1a50c72e98297…

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Pramipexole dihydrochloridePRAMIPEXOLE DIHYDROCHLORIDEGlenmark Pharmaceuticals Inc., USA44c336d2-01d1-4f13-bad9-549cdc3505ec2025-12-30Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090781
application number: ANDA090781
ndc (product): 68462-332
ndc (product): 68462-330
ndc (product): 68462-334
ndc (product): 68462-331
ndc (product): 68462-333
ndc (product): 68462-627
Pramipexole dihydrochloridePRAMIPEXOLE DIHYDROCHLORIDENCS HealthCare of KY, LLC dba Vangard Labs5e6f2187-a5cc-481e-b0a1-d38d3f92e8222024-10-09Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090781
application number: ANDA090781

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 29 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50090-2190Pramipexole dihydrochloridePramipexole dihydrochlorideA-S Medication SolutionsANDACurrent
50090-2190Pramipexole dihydrochloridePramipexole dihydrochlorideA-S Medication SolutionsANDACurrent
50090-2190Pramipexole dihydrochloridePramipexole dihydrochlorideA-S Medication SolutionsANDACurrent
50090-2217Pramipexole dihydrochloridePramipexole dihydrochlorideA-S Medication SolutionsANDACurrent
68462-330Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-330Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-330Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-330Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-331Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-331Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-331Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-331Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-332Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-332Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-332Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-332Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-333Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-333Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-333Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-333Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-334Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-334Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-334Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-334Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-627Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-627Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-627Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-627Pramipexole dihydrochloridePramipexole dihydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
70934-596Pramipexole dihydrochloridePramipexole dihydrochlorideDenton Pharma, Inc. dba Northwind PharmaceuticalsANDACurrent